| TD | ASD | Overall | p-value |
---|---|---|---|---|
(N = 105) | (N = 140) | (N = 245) |  | |
Age (Year 1) | 10.58 11.67 12.67 | 10.50 11.25 12.25 | 10.58 11.33 12.33 | 0.0811 |
Age (Year 2) | 11.76 12.74 13.82 | 11.70 12.46 13.52 | 11.73 12.65 13.62 | 0.2451 |
Age (Year 3) | 12.75 13.68 14.79 | 12.68 13.37 14.43 | 12.74 13.53 14.51 | 0.1831 |
Age (Year 4) | 13.75 14.59 15.56 | 13.75 14.42 15.40 | 13.74 14.48 15.48 | 0.5491 |
Change in Age (Y1 – Y4) | 3.13 3.18 3.27 | 3.14 3.18 3.30 | 3.13 3.18 3.28 | 0.4911 |
Sex | Â | Â | Â | 0.0032 |
 Male | 0.56  59/105 | 0.74  104/140 | 0.67  163/245 |  |
 Female | 0.44  46/105 | 0.26  36/140 | 0.33  82/245 |  |
Ethnicity | Â | Â | Â | 0.3322 |
 Not Hispanic | 0.95  100/105 | 0.92  129/140 | 0.93  229/245 |  |
 Hispanic | 0.05  5/105 | 0.08  11/140 | 0.07  16/245 |  |
Race | Â | Â | Â | 0.0023 |
 Caucasian | 0.86  90/105 | 0.81  114/140 | 0.83  204/245 |  |
 African American | 0.02  2/105 | 0.12  17/140 | 0.08  19/245 |  |
 American Indian | 0.00  0/105 | 0.00  0/140 | 0.00  0/245 |  |
 Asian/Pacific Islander | 0.00  0/105 | 0.01  1/140 | 0.00  1/245 |  |
 Biracial | 0.12  13/105 | 0.06  8/140 | 0.09  21/245 |  |
BMI (Percentile, Year 1) | 30.00 53.00 87.00 | 39.25 69.00 95.75 | 34.00 63.00 93.00 | 0.0141 |
GB Development (Year 1) | 1.00 2.00 3.00 | 1.00 2.00 3.00 | 1.00 2.00 3.00 | 0.8351 |
GB Development (Year 2) | 2.00 2.00 4.00 | 2.00 3.00 4.00 | 2.00 3.00 4.00 | 0.2501 |
GB Development (Year 3) | 2.00 4.00 5.00 | 3.00 4.00 5.00 | 3.00 4.00 5.00 | 0.8241 |
GB Development (Year 4) | 4.00 4.00 5.00 | 4.00 5.00 5.00 | 4.00 5.00 5.00 | 0.5331 |
GB Development (Y1-Y4) | 2.00 2.00 3.00 | 1.00 2.00 3.00 | 1.00 2.00 3.00 | 0.1051 |
Cortisol (Year 1) | 6.90 9.09 12.16 | 6.11 8.02 10.92 | 6.39 8.55 11.41 | 0.0561 |
Cortisol (Year 4) | 6.55 9.03 12.32 | 6.14 8.66 10.94 | 6.40 8.81 11.37 | 0.2701 |
Testosterone (Year 1) | 0.00 0.00 0.01 | 0.00 0.01 0.03 | 0.00 0.01 0.02 | 0.1831 |
Testosterone (Year 4) | 0.02 0.07 0.13 | 0.03 0.10 0.17 | 0.02 0.09 0.15 | 0.2021 |